Hims & Hers Health HIMS
NYSE HIMS
$31.84 +0.75 (+2.41%)
As of: Aug 20, 2026 · 3:59 PM EDT

Hims & Hers Health (HIMS) Cash & Current Investments (2019 - 2026)

Hims & Hers Health (HIMS) posted Cash & Current Investments of $750.9 million for Q1 2026, up 30.02% sequentially from $577.5 million in Q4 2025, and up 132.71% YoY from $322.7 million in Q1 2025.

Hims & Hers Health (HIMS) Cash & Current Investments (2019 - 2026) Analysis & Trends

Hims & Hers Health has reported Cash & Current Investments for 8 years, with the latest figure at $750.9 million in Q1 2026.

  • Quarterly Cash & Current Investments rose 132.71% year-over-year to $750.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $750.9 million (up 132.71% YoY) and the FY2025 annual result came in at $577.5 million, up 92.34% from the prior year.
  • Cash & Current Investments improved to $750.9 million in Q1 2026 per HIMS's latest filing, from $577.5 million in the prior quarter.
  • Over five years, Cash & Current Investments peaked at $1.1 billion in Q2 2025 and troughed at $179.6 million in Q4 2022.
  • A 5-year average of $352.8 million and a median of $221.0 million in 2023 frame the typical range for Cash & Current Investments.
  • The sharpest annual moves came in 2022 and 2025: Cash & Current Investments sank 38.56% in 2022, then surged 403.59% in 2025.
  • Over 5 years, Cash & Current Investments stood at $179.6 million in 2022, then advanced by 23.02% to $221.0 million in 2023, then surged by 35.87% to $300.3 million in 2024, then soared by 92.34% to $577.5 million in 2025, then surged by 30.02% to $750.9 million in 2026.
  • According to Business Quant data, Cash & Current Investments over the past three periods registered $750.9 million, $577.5 million, and $629.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Haleon 43.83 Bn 42.86 Bn - 963.33 Mn
2 Teva Pharmaceutical Industries 42.87 Bn 39.22 Bn 2.15 Bn 3.66 Bn
3 Zoetis 31.41 Bn 29.73 Bn 1.05 Bn 1.68 Bn
4 Takeda Pharmaceutical 28.55 Bn 22.75 Bn 5.10 Bn 5.80 Bn
5 United Therapeutics 22.08 Bn 19.42 Bn 683.80 Mn 2.66 Bn
6 Viatris 18.73 Bn 17.84 Bn 1.46 Bn 886.50 Mn
7 Neurocrine Biosciences 15.44 Bn 15.05 Bn 935.80 Mn 389.80 Mn
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn 530.00 Mn
9 Dr Reddys Laboratories 10.11 Bn 9.94 Bn - 164.00 Mn
10 Hims & Hers Health 7.42 Bn 6.57 Bn 480.80 Mn 841.05 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 841.05 Mn
Mar 31, 2026 750.88 Mn
Dec 31, 2025 577.49 Mn
Sep 30, 2025 629.74 Mn
Jun 30, 2025 1.14 Bn
Mar 31, 2025 322.67 Mn
Dec 31, 2024 300.25 Mn
Sep 30, 2024 254.07 Mn
Jun 30, 2024 227.29 Mn
Mar 31, 2024 203.59 Mn
Dec 31, 2023 220.98 Mn
Sep 30, 2023 212.50 Mn
Jun 30, 2023 193.14 Mn
Mar 31, 2023 184.39 Mn
Dec 31, 2022 179.63 Mn
Sep 30, 2022 198.39 Mn
Jun 30, 2022 194.98 Mn
Mar 31, 2022 203.05 Mn
Dec 31, 2021 247.27 Mn
Sep 30, 2021 252.43 Mn